Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.

Misset, J L; di Palma, M; Delgado, M; Plagne, R; Chollet, P; Fumoleau, P; Le Mevel, B; Belpomme, D; Guerrin, J; Fargeot, P; Metz, R; Ithzaki, M; Hill, C; Mathé, G

期刊名称Journal of Clinical Oncology
作者Misset, J L; di Palma, M; Delgado, M; Plagne, R; Chollet, P; Fumoleau, P; Le Mevel, B; Belpomme, D; Guerrin, J; Fargeot, P; Metz, R; Ithzaki, M; Hill, C; Mathé, G
卷第14卷
期第4期
印刷ISSN0732-183X
电子ISSN1527-7755
文件大小861.33KB
发表时间1996-04
DOI10.1200/jco.1996.14.4.1136
页码1136-1145

发现好书期刊，享受阅读乐趣

Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.